Arthritis Research Yields Breakthrough in Early Detection

Vail, Colorado-Peter J. Millett M.D., M.Sc. of the Steadman Hawkins Clinic has led a team of researchers who have made a pioneering breakthrough in osteoarthritis research by discovering a molecular “fingerprint” for osteoarthritis.

Among the over 100 types of arthritis, osteoarthritis is the most common. The establishment of a “fingerprint” or biomarker heralds an important first step in the diagnosis and understanding this disease that afflicts over 20 million people in the United States alone.

The discovery was made by the Musculoskeletal Proteomics research group at Harvard, which was directed by Dr. Millett. Proteomics is emerging as a powerful new field of research with enormous potential to influence disease diagnosis and treatment. Proteomics allows for the study of proteins — the active molecules in all biologic systems, and the discovery of the biomarker is only the beginning.

“The breakthroughs we have made in establishing a molecular fingerprint for osteoarthritis are extremely pivotal. With the discovery of this new biomarker, we now have a foundation from which we can identify new protein targets for improved diagnostic tests and for better treatments that will help those afflicted with osteoarthritis” says Millett.

The physicians of the Steadman Hawkins Clinic in Vail are known around the world for innovative approaches to orthopaedic treatment and research. Through the award-winning research foundation, the clinic has introduced new surgical techniques and minimally invasive procedures, making it a leader in orthopaedic and sports medicine.

Dr. Millett looks forward to future breakthroughs that are sure to follow in proteomics and osteoarthritis, ultimately improving the health of millions affected by the degenerative disease.